Abacavir Sulfate (188062-50-2): A Deep Dive

Abacavir salt sulfate, identified by the CAS number 188062502 , is a crucial antiviral utilized in the management of HIV illness. Its mechanism of action involves inhibiting reverse transcriptase , a vital protein for viral copying. Patients receiving this substance must undergo genetic screening prior to commencement, due to a risk of hypersensitivity response linked to the HLA-B*57:01 allele. This adverse effect can range from mild rash to a severe, life-threatening emergency. Careful assessment and patient counseling are therefore imperative for safe and successful utilization of abacavir sulfate .

Abarelix: Delving into Compound 183552-38-7

Abarelix, identified as compound 183552-38-7, is a synthetic decapeptide developed for the therapy of benign prostatic hyperplasia . This medication functions as a specific gonadotropin-releasing hormone (GnRH) inhibitor, effectively reducing male hormone production. Research into this agent has focused on its ability to alleviate associated conditions and potentially give an alternative to conventional interventions. The molecular profile of 183552-38-7 is intricate, showcasing a particular amino acid sequence resulting in its specific mechanism of action . More clinical studies are being conducted to completely evaluate its future security and power.

Abiraterone Acetate: Properties and Identification via CAS 154229-18-2

Abiraterone salt is a copyrightal blocker of CYP17A1, an protein crucial for androgen biosynthesis. Its structural formula is C26H30O3, and it’s commonly identified by its Chemical Abstracts Service (CAS) Registry Number 154229-18-2, providing the identifier for precise identification. The compound's properties include high affinity for CYP17A1, resulting in lower androgen levels and exhibiting certain white to off-white solid appearance. Further analysis using analytical techniques is typically conducted to establish identity and quality .

CAS Number Spotlight: Abacavir Sulfate Form – 188062-50-2 CAS

This article focuses on a important pharmaceutical compound : Abacavir Sulfate Form, identified by its unique Chemical Abstracts Service (CAS) number : 188062-50-2. It is a key part in the treatment of the HIV infection, frequently prescribed in along with other reverse transcriptase inhibitor medications . Knowing this identification designation is useful for professionals in the healthcare field.

Key aspects regarding Abacavir Sulfate Form:

  • Function : Works as a nucleoside reverse transcriptase blocker .
  • Utility: Primarily used in the HIV therapy .
  • Verification: The chemical number 188062-50-2 ensures accurate labeling .

Investigating Abarelix: Molecular Structure (183552-38-7)

Abarelix, identified by the registration identifier 183552-38-7, represents a fascinating example within the realm of peptide study. Its intricate arrangement is crucial to its clinical activity. Fundamentally, this compound is a synthetic decapeptide, AFLOQUALONE  56287-74-2 designed to target and interfere with gonadotropin-releasing GnRH hormone. The chemical formula reveals a sequence of building blocks carefully arranged to obtain a specific affinity with the GnRH receptor.

  • Additional research are conducted to fully elucidate its mode of action.
  • Understanding its manufacture is vital for expanding production.
  • The precise chain dictates its strength.

Abiraterone Acetate (154229-18-2): Uses and Chemical Characteristics

{Abiraterone Compound, with the CAS number 154229-18-2, is a drug primarily employed in the therapy of metastatic male tumor, specifically those demonstrating mutations in the PTEN pathway. It functions as an suppressor of cytochrome P450c17, an enzyme responsible for male hormone production . Chemically, it’s a synthetic copyright with a complex makeup, intended to effectively reduce androgen levels. Its therapeutic application has significantly improved outcomes for patients with late-stage prostate disease .

Leave a Reply

Your email address will not be published. Required fields are marked *